Philadelphia Chromosome-Positive Acute Myeloid Leukemia with Masses and Osteolytic Lesions: Finding of 18F-Fdg Pet/Ct

Zhan Su,Fengyu Wu,Weiyu Hu,Xiaodan Liu,Shaoling Wu,Xianqi Feng,Zhongguang Cui,Jie Yang,Zhenguang Wang,Hongzai Guan,Hongguo Zhao,Wei Wang,Chunting Zhao,Jun Peng
DOI: https://doi.org/10.1007/s11684-017-0523-x
2017-01-01
Frontiers of Medicine
Abstract:Philadelphia chromosome-positive acute myeloid leukemia is controversial and difficult to distinguish from the blast phase of chronic myeloid leukemia. As a myeloid neoplasm, rare cases of this leukemia manifest multiple soft-tissue tumors or bone lytic lesions. In this paper, we describe a 49-year-old male patient who had an abrupt onset with sharp chest pain, fever, fatigue, emaciation, and splenomegaly. 18F-fluoro-deoxy-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) result showed diffuse and uneven hypermetabolic lesions in the bone marrow with peripheral bone marrow expansion, multiple soft tissue neoplasms with high 18F-FDG uptake, and lytic bone lesions. Bone marrow smear and biopsy detected aberrant blast cells expressing myeloid rather than lymphoid immunophenotype marker. For the existence of Philadelphia chromosome and BCR-ABL1 fusion gene together with complex chromosome abnormalities, a diagnosis of Philadelphia-positive acute myeloid leukemia was made, although the type (de novo or blast crisis) remained unclear.
What problem does this paper attempt to address?